Stone Warren's Form 4 filing
Neogenomics Inc (NEO) · filed May 13, 2025
- Accession no.
- 0001077183-25-000104
- Filed
- May 13, 2025
- Trade date
- May 11-12, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market purchases total $48.9K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Stone WarrenCIK 0001955295 | Officer (Pres & Chief Operating Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 11, 2025 | Common Stock | MOption exerciseAcquired | +9,613 | $0.00 | $0 | 104,921 | Direct | |
| May 11, 2025 | Common Stock | FTax withholdingDisposed | −2,341 | $0.00 | $0 | 102,580 | Direct | |
| May 12, 2025 | Common Stock | PPurchaseAcquired | +5,700 | $8.58 | +$48,906 | 108,280 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 11, 2025 | Common Stock | MOption exerciseDisposed | −9,613 | $0.00 | $0 | 9,613 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.